Evaluation of a rapid in vitro androgen receptor transcriptional activation assay using AR-EcoScreen™ cells

被引:39
作者
Araki, N
Ohno, K
Takeyoshi, M
Iida, M
机构
[1] Otsuka Pharmaceut Co Ltd, Otsuka Life Sci Initiative, EcoScreen R&D Sect, Endocrine Disrupting Chem Anal Ctr, Tokushima 7710195, Japan
[2] Chem Evaluat & Res Inst, Chem Assessment Ctr, Oita 8770061, Japan
关键词
androgen receptor; AR-EcoScreen (TM); endocrine disruptor; high-throughput screening; prevalidation; reporter gene assay;
D O I
10.1016/j.tiv.2004.10.008
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
An accurate and reliable in vitro assay system has been needed for first tier screening of endocrine disrupting chemicals. For the purpose, we previously developed stable AR-EcoScreen (TM) cell lines to assess androgen receptor (AR)-mediated transcriptional activation. In this report, we evaluated AR-EcoScreen (TM) cell lines as the phase I of prevalidation study by determining the intra-laboratory reproducibility, assay stability, and overall protocol performance of AR-EcoScreen (TM) assays. Forty compounds recommended by the ICCVAM were tested for AR agonist and antagonist activity. The mean coefficient of variation (CV) for intra-assay reproducibility in the AR agonist assay was 4.35% for 5 alpha-dihydrotestosterone (DHT), and that for the antagonist assay was 5.51% for hydroxyflutamide. The detection limit of the agonist assay was 2.3 x 10(-11) M for 5 alpha-dihydrotestosterone. Furthermore, we examined the overall performance of the method by comparing the predicted result with the ICCVAM classification. Thus, the overall sensitivity, specificity, and accuracy of the agonist assay were 89%, 94%, and 91%, respectively. For the antagonist assay, these values were 94%, 100%, and 96%, respectively. In summary, we concluded that AR-EcoScreen (TM) method was ready to proceed to the phase II prevalidation study to asses the inter-laboratory variability and transfer of the protocol. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:335 / 352
页数:18
相关论文
共 32 条
[1]   Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor [J].
Blankvoort, BMG ;
de Groene, EM ;
van Meeteren-Kreikamp, AP ;
Witkamp, RF ;
Rodenburg, RJT ;
Aarts, JMMJG .
ANALYTICAL BIOCHEMISTRY, 2001, 298 (01) :93-102
[2]  
CURREN RD, 1995, ATLA-ALTERN LAB ANIM, V23, P211
[3]   Uncertainties for endocrine disrupters: Our view on progress [J].
Daston, GP ;
Cook, JC ;
Kavlock, RJ .
TOXICOLOGICAL SCIENCES, 2003, 74 (02) :245-252
[4]   Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay [J].
Gaido, KW ;
Leonard, LS ;
Lovell, S ;
Gould, JC ;
Babai, D ;
Portier, CJ ;
McDonnell, DP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 143 (01) :205-212
[5]   MDA-MB-453, AN ANDROGEN-RESPONSIVE HUMAN BREAST-CARCINOMA CELL-LINE WITH HIGH-LEVEL ANDROGEN RECEPTOR EXPRESSION [J].
HALL, RE ;
BIRRELL, SN ;
TILLEY, WD ;
SUTHERLAND, RL .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) :484-490
[6]   Development of two androgen receptor assays using adenoviral transduction of MMTV-Luc reporter and/or hAR for endocrine screening [J].
Hartig, PC ;
Bobseine, KL ;
Britt, BH ;
Cardon, MC ;
Lambright, CR ;
Wilson, VS ;
Gray, LE .
TOXICOLOGICAL SCIENCES, 2002, 66 (01) :82-90
[7]  
Holzhutter HG, 1996, ATLA-ALTERN LAB ANIM, V24, P511
[8]  
*INT COORD COMM VA, 2003, 034503 NIH PUBL
[9]   The OECD program to validate the rat uterotrophic bioassay. Phase 2: Coded single-dose studies [J].
Kanno, J ;
Onyon, L ;
Peddada, S ;
Ashby, J ;
Jacob, E ;
Owens, W .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (12) :1550-1558
[10]   PERSISTENT DDT METABOLITE P,P'-DDE IS A POTENT ANDROGEN RECEPTOR ANTAGONIST [J].
KELCE, WR ;
STONE, CR ;
LAWS, SC ;
GRAY, LE ;
KEMPPAINEN, JA ;
WILSON, EM .
NATURE, 1995, 375 (6532) :581-585